Harmony Biosciences (HRMY)
(Delayed Data from NSDQ)
$37.76 USD
+0.48 (1.29%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $37.75 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Earnings News For HRMY
-
Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q2 Earnings and Revenue Estimates
-
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
-
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
-
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q4 Earnings and Revenue Estimates
-
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
-
Harmony Biosciences Holdings, Inc. (HRMY) Lags Q3 Earnings Estimates
-
Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
-
Earnings Preview: Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Expected to Decline
-
Harmony Biosciences Holdings, Inc. (HRMY) Lags Q2 Earnings and Revenue Estimates
-
Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates
-
Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q1 Earnings and Revenue Estimates
-
Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates
-
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings and Revenues Beat Estimates
-
Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
-
Harmony Biosciences Holdings, Inc. (HRMY) Beats Q3 Earnings and Revenue Estimates
-
Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates
-
Analysts Estimate Harmony Biosciences Holdings, Inc. (HRMY) to Report a Decline in Earnings: What to Look Out for
-
Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q2 Earnings and Revenue Estimates
-
Harmony Biosciences Holdings, Inc. (HRMY) Beats Q1 Earnings Estimates
-
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings and Revenues Surpass Estimates
-
Harmony Biosciences Holdings, Inc. (HRMY) Tops Q3 Earnings and Revenue Estimates
-
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release